GLYSTALI

Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use